Saliva substitute in xerostomic patients with primary Sjogren's syndrome: a single-blind trial (2004)
- Autores:
- Autor USP: MIGLIARI, DANTE ANTONIO - FO
- Unidade: FO
- Assuntos: XEROSTOMIA; SALIVA ARTIFICIAL; SÍNDROME DE SJOGREN
- Idioma: Inglês
- Resumo: OBJECTIVE: To evaluate the efficacy of oral moisturizing gel (Oral Balance) in xerostomic patients with primary Sjogren's syndrome (SS). METHOD AND MATERIALS: Twenty-one xerostomic patients with primary SS were subjected to a single-blind trial in which the efficacy of Oral Balance gel in reducing xerostomia and xerostomia-related oral symptoms was compared with that of a placebo. Both gels were packaged identically and were indiscernible in appearance and taste. Xerostomia was confirmed for all the patients through measurement of stimulated whole saliva. Patients began using the Oral Balance gel three times a day for 90 days, and were then switched to a gel placebo to be used in the same way for the same length of time. Clinical response was evaluated through the patients' subjective assessment (improved, worsened, or unaltered) of both gels. RESULTS: Neither the Oral Balance gel nor the gel placebo affected the salivary output of the patients. The Oral Balance gel presented a substantial statistically significant advantage in the control of burning mouth, mastication, and swallowing. No statistically significant relief of the isolated sensation of oral dryness was established. CONCLUSION: Oral Balance is a useful tool in the management of dryness-related oral symptoms in primary SS, but there is room for enhancing the overall properties of topical preparations designed to reduce oral complaints in xerostomic patients
- Imprenta:
- Local: Carol Stream
- Data de publicação: 2004
- Fonte:
- Título do periódico: Quintessence International
- ISSN: 0033-6572
- Volume/Número/Paginação/Ano: v. 35, n. 5, p.392-396, May 2004
-
ABNT
ALVES, Marilene B. et al. Saliva substitute in xerostomic patients with primary Sjogren's syndrome: a single-blind trial. Quintessence International, v. 35, n. 5, p. 392-396, 2004Tradução . . Acesso em: 23 abr. 2024. -
APA
Alves, M. B., Motta, A. C. F., Messina, W. C., & Migliari, D. A. (2004). Saliva substitute in xerostomic patients with primary Sjogren's syndrome: a single-blind trial. Quintessence International, 35( 5), 392-396. -
NLM
Alves MB, Motta ACF, Messina WC, Migliari DA. Saliva substitute in xerostomic patients with primary Sjogren's syndrome: a single-blind trial. Quintessence International. 2004 ; 35( 5): 392-396.[citado 2024 abr. 23 ] -
Vancouver
Alves MB, Motta ACF, Messina WC, Migliari DA. Saliva substitute in xerostomic patients with primary Sjogren's syndrome: a single-blind trial. Quintessence International. 2004 ; 35( 5): 392-396.[citado 2024 abr. 23 ] - Binding of calmodulin to hydroxyapatite
- Oral lesions in 166 patients with cutaneous psoriasis: a controlled study
- Líquen plano oral: fatores associados à ansiedade e depressão
- Diagnosing oral lichenoid contact reaction: clinical judgment versus skin-patch test
- Lip and oral venous varices treated by photocoagulation with high-intensity diode laser
- Niveis da iga secretoria na saliva total nao-estimulada, de individuos fumantes e nao-fumantes por imunodifusao radial simples
- Estudo in vitro da pelicula adquirida do esmalte derivada da saliva total
- Corticoterapia tópica no tratamento das gengivites descamativas
- Hyperplastic candidosis on the palate developed as a "kissing" lesion from median rhomboid glossitis
- Frequência da infecção pelo herpes simples, mediante aplicação de questionário, na população do campus da Cidade Universitária - USP
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
